Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
|
|
ARATANA THERAPEUTICS, INC. (PETX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/29/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/29/2019 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 07/22/2019 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Disposed/sold 7,258,135 shares
@ $0 |
|
| 07/22/2019 |
SC 13G/A
| Broadfin Capital, LLC reports a 0% stake in Aratana Therapeutics, Inc. |
| 07/22/2019 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/22/2019 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/18/2019 |
4
| YARNO WENDY L (Director) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Disposed/sold 18,000 shares
@ $0
Disposed/sold 13,237 options to buy
@ $28.04, valued at
$371.2k
Disposed/sold 10,000 options to buy
@ $15.03, valued at
$150.3k
Disposed/sold 10,000 options to buy
@ $14.27, valued at
$142.7k
Disposed/sold 7,500 options to buy
@ $6.12, valued at
$45.9k
Disposed/sold 7,500 options to buy
@ $6.84, valued at
$51.3k
Disposed/sold 7,500 options to buy
@ $4.36, valued at
$32.7k
Disposed/sold 7,500 options to buy
@ $4.8, valued at
$36k
|
|
| 07/18/2019 |
4
| Vander Vort John (Director) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Disposed/sold 43,000 shares
@ $0
Disposed/sold 13,237 options to buy
@ $6, valued at
$79.4k
Disposed/sold 10,000 options to buy
@ $15.03, valued at
$150.3k
Disposed/sold 10,000 options to buy
@ $14.27, valued at
$142.7k
Disposed/sold 7,500 options to buy
@ $6.12, valued at
$45.9k
Disposed/sold 7,500 options to buy
@ $6.84, valued at
$51.3k
Disposed/sold 7,500 options to buy
@ $4.36, valued at
$32.7k
Disposed/sold 7,500 options to buy
@ $4.8, valued at
$36k
|
|
| 07/18/2019 |
4
| TOOMAN CRAIG A (President and CEO) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Disposed/sold 307,501 shares
@ $0
Disposed/sold 15,042 options to buy
@ $0.4, valued at
$6k
Disposed/sold 6,016 options to buy
@ $5.57, valued at
$33.5k
Disposed/sold 90,450 options to buy
@ $21.14, valued at
$1.9M
Disposed/sold 25,000 options to buy
@ $18.42, valued at
$460.5k
Disposed/sold 32,500 options to buy
@ $17.18, valued at
$558.4k
Disposed/sold 57,500 options to buy
@ $3.14, valued at
$180.6k
Disposed/sold 45,000 options to buy
@ $8.02, valued at
$360.9k
Disposed/sold 60,000 options to buy
@ $4.83, valued at
$289.8k
Disposed/sold 222,222 options to buy
@ $4.22, valued at
$937.8k
|
|
| 07/18/2019 |
4
| ROCHE ROBERT P JR (Director) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Disposed/sold 18,000 shares
@ $0
Disposed/sold 20,000 options to buy
@ $15.8, valued at
$316k
Disposed/sold 10,000 options to buy
@ $14.27, valued at
$142.7k
Disposed/sold 7,500 options to buy
@ $6.12, valued at
$45.9k
Disposed/sold 7,500 options to buy
@ $6.84, valued at
$51.3k
Disposed/sold 7,500 options to buy
@ $4.36, valued at
$32.7k
Disposed/sold 7,500 options to buy
@ $4.8, valued at
$36k
|
|
| 07/18/2019 |
4
| ROBINSON LOWELL W (Director) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Disposed/sold 4,500 shares
@ $0
Disposed/sold 30,000 options to buy
@ $5.34, valued at
$160.2k
Disposed/sold 7,500 options to buy
@ $4.8, valued at
$36k
|
|
| 07/18/2019 |
4
| READY CHRISTOPHER T (VP of Sales and Marketing) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Disposed/sold 53,728 shares
@ $0
Disposed/sold 17,500 options to buy
@ $7.34, valued at
$128.5k
Disposed/sold 16,600 options to buy
@ $4.83, valued at
$80.2k
Disposed/sold 53,943 options to buy
@ $4.22, valued at
$227.6k
|
|
| 07/18/2019 |
4
| RAINES MERILEE (Director) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Disposed/sold 18,000 shares
@ $0
Disposed/sold 13,237 options to buy
@ $21.17, valued at
$280.2k
Disposed/sold 10,000 options to buy
@ $14.27, valued at
$142.7k
Disposed/sold 7,500 options to buy
@ $6.12, valued at
$45.9k
Disposed/sold 7,500 options to buy
@ $6.84, valued at
$51.3k
Disposed/sold 7,500 options to buy
@ $4.36, valued at
$32.7k
Disposed/sold 7,500 options to buy
@ $4.8, valued at
$36k
|
|
| 07/18/2019 |
4
| Hockaday Irvine O Jr (Director) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Disposed/sold 82,985 shares
@ $0
Disposed/sold 20,000 options to buy
@ $11.18, valued at
$223.6k
Disposed/sold 10,000 options to buy
@ $14.27, valued at
$142.7k
Disposed/sold 7,500 options to buy
@ $6.12, valued at
$45.9k
Disposed/sold 7,500 options to buy
@ $6.84, valued at
$51.3k
Disposed/sold 7,500 options to buy
@ $4.36, valued at
$32.7k
Disposed/sold 7,500 options to buy
@ $4.8, valued at
$36k
|
|
| 07/18/2019 |
4
| HELLUMS RHONDA LYNETTE (CFO) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Disposed/sold 51,424 shares
@ $0
Disposed/sold 25,000 options to buy
@ $22.91, valued at
$572.8k
Disposed/sold 2,650 options to buy
@ $17.18, valued at
$45.5k
Disposed/sold 6,700 options to buy
@ $3.14, valued at
$21k
Disposed/sold 4,100 options to buy
@ $8.02, valued at
$32.9k
Disposed/sold 14,700 options to buy
@ $4.83, valued at
$71k
Disposed/sold 15,100 options to buy
@ $4.22, valued at
$63.7k
Disposed/sold 67,527 options to buy
@ $4.44, valued at
$299.8k
|
|
| 07/18/2019 |
4
| HEINEN ERNST (Chief Development Officer) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Disposed/sold 170,617 shares
@ $0
Disposed/sold 30,084 options to buy
@ $6, valued at
$180.5k
Disposed/sold 50,000 options to buy
@ $18.42, valued at
$921k
Disposed/sold 25,000 options to buy
@ $17.18, valued at
$429.5k
Disposed/sold 70,000 options to buy
@ $3.14, valued at
$219.8k
Disposed/sold 37,500 options to buy
@ $8.02, valued at
$300.8k
Disposed/sold 60,000 options to buy
@ $4.83, valued at
$289.8k
Disposed/sold 82,627 options to buy
@ $4.22, valued at
$348.7k
|
|
| 07/18/2019 |
4
| Brinkley David L (Director) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Disposed/sold 18,000 shares
@ $0
Disposed/sold 13,237 options to buy
@ $18.97, valued at
$251.1k
Disposed/sold 10,000 options to buy
@ $14.27, valued at
$142.7k
Disposed/sold 7,500 options to buy
@ $6.12, valued at
$45.9k
Disposed/sold 7,500 options to buy
@ $6.84, valued at
$51.3k
Disposed/sold 7,500 options to buy
@ $4.36, valued at
$32.7k
Disposed/sold 7,500 options to buy
@ $4.8, valued at
$36k
|
|
| 07/18/2019 |
4
| Barbarosh Craig A. (Director) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Disposed/sold 4,500 shares
@ $0
Disposed/sold 30,000 options to buy
@ $5.34, valued at
$160.2k
Disposed/sold 7,500 options to buy
@ $4.8, valued at
$36k
|
|
| 07/18/2019 |
4
| AYRES JOHN C (SEE REMARKS) has filed a Form 4 on ARATANA THERAPEUTICS, INC.|
Txns:
| Disposed/sold 129,889 shares
@ $0
Disposed/sold 66,667 options to buy
@ $20.4, valued at
$1.4M
Disposed/sold 20,000 options to buy
@ $18.42, valued at
$368.4k
Disposed/sold 25,000 options to buy
@ $17.18, valued at
$429.5k
Disposed/sold 70,000 options to buy
@ $3.14, valued at
$219.8k
Disposed/sold 37,500 options to buy
@ $8.02, valued at
$300.8k
Disposed/sold 60,000 options to buy
@ $4.83, valued at
$289.8k
Disposed/sold 82,627 options to buy
@ $4.22, valued at
$348.7k
|
|
| 07/18/2019 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 07/18/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/18/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/18/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/18/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/18/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/18/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/18/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/18/2019 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 07/18/2019 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 07/18/2019 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 07/16/2019 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits |
| 07/02/2019 |
8-K
| Other Events |
| 07/02/2019 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 06/24/2019 |
GN
| Rigrodsky & Long, P.A. Files Class Action Suit Against Aratana Therapeutics, Inc. |
|
|
|